Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenaline for Prevention of Intubation-Related Hypotension in Cardiac or Thoracic Surgery
NCT05335954Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of norepinephrine in hypotension (2 arms), sponsored by CHU de Nantes. Primary endpoint: Intubation-related hypotension at 20 minutes. Started Apr 2022; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05335954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335954.